As of April 16, 2025, Monopar Therapeutics (MNPR) has a market cap of $0.23 billion USD. According to our data, Monopar Therapeutics is ranked No.6809 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.23 B |
74.65%
|
Dec 31, 2024 | $0.13 B |
1,194.12%
|
Dec 29, 2023 | $10.37 M |
-85.65%
|
Dec 30, 2022 | $72.31 M |
-26.17%
|
Dec 31, 2021 | $97.95 M |
-47.55%
|
Dec 31, 2020 | $0.19 B |
-63.13%
|
Dec 31, 2019 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Karyopharm Therapeutics
KPTI
|
$35.85 M |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() CytomX Therapeutics
CTMX
|
$50.58 M |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() Agenus
AGEN
|
$42.77 M |
-0.000 M
|
![]() USA
|
Market Cap | = | MNPR Stock Price | * | MNPR Shares Outstanding |
= | $38.36 | * | 6.11 M | |
= | $0.23 B |